FDA recall record

Duren Health Mart Pharmacy Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription recall — FDA D-0416-2019

Lack of Processing Controls.

Class IIclassification
D-0416-2019official record ID
Feb 6, 2019report date

Recall record at a glance

Official recordD-0416-2019
CategoryDrug Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmDuren Health Mart Pharmacy
Report dateFeb 6, 2019
Recall initiation dateDec 17, 2018
Quantity2700 cc
LocationWaynesboro, TN, United States

Official product description

Omeprazole 4 mg/mL Suspension, 150cc to 300 cc per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN 38485, NDC 00000-0001-07

Why the product was recalled

Lack of Processing Controls.

Distribution information

TN only

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.